Oncologia Integrativa
Terapie Naturali Complementari per il Cura del Cancro
Terapie naturali alternative con proprietà analgesiche, antinfiammatorie e immunostimolanti che alleviano i sintomi del cancro ed estendono la sopravvivenza.
Come Lavoriamo
Stage 3–4 cancer support
Immunostimulant therapies
Pain management
Quality of life improvement
Nutritional oncology support
Psychological support
Iniziate il Vostro Viaggio Verso la Guarigione
Inviate la vostra anamnesi e i referti, e i nostri specialisti valuteranno il vostro caso raccomandando un piano di trattamento personalizzato per le vostre esigenze.
Richiedi un ConsultoWhatsAppI Nostri Programmi Medici a Colpo d'Occhio
Confronta focus, terapie chiave, soggiorno e candidati ideali dei nostri programmi principali.
| Programma | Focus Principale | Terapia / Innovazione Chiave | Soggiorno Tipico | Setting di Cura | Ideale Per |
|---|---|---|---|---|---|
| Oncologia Integrativa | Supporto tumore avanzato e metastatico | CIMAvax-EGF®, VAXIRA®, HEBERSaVax®, VIDATOX® | 2–4 settimane | Ricovero e ambulatoriale | Pazienti tumore stadio 3–4 |
| Riabilitazione Fisica | Recupero neurologico, ortopedico e cardiopolmonare | NeuralCIM®, fisioterapia avanzata | 3–6 settimane | Ricovero intensivo | Ictus, TBI, post-chirurgia |
| Trattamento del Piede Diabetico | Ulcera del piede diabetico e salvataggio dell'arto | Heberprot-P®, cura avanzata delle ferite | 2–6 settimane | Ricovero e ambulatoriale | Ulcere diabetiche, rischio gangrena |
| Rilevamento Vascolare Precoce | Rilevazione precoce del rischio vascolare | Screening vascolare non invasivo | 2–5 giorni | Screening ambulatoriale | Screening cardiovascolare preventivo |
| Emodialisi in Vacanza | Cura renale continua in viaggio | Emodialisi moderna + nefrologia | Per seduta / continuo | Stazione emodialisi ambulatoriale | Pazienti in dialisi in visita a Cuba |
| Medicina Ayurvedica | Disintossicazione olistica e supporto malattie croniche | Panchakarma, fitoterapia, yoga | 2–3 settimane | Residenza benessere | Stress, patologie croniche, disintossicazione |
| Qualità della Vita | Valutazione salute preventiva e benessere | Screening, pianificazione dello stile di vita | 3–7 giorni | Valutazione ambulatoriale | Adulti attenti alla salute, check-up esecutivi |
| Trattamento delle Dipendenze | Recupero dipendenze da sostanze e comportamentali | Disintossicazione, terapia psichiatrica e comportamentale | 4–8 settimane | Ricovero in natura | Dipendenze da sostanze e comportamentali |
I soggiorni sono stime; il piano personalizzato è confermato dopo la consulenza medica.
Medical Evaluation Process
A clear, structured process guides you from first contact through to the completion of treatment.
1. Initial Consultation Request
Submit your medical records and treatment inquiry through our secure online consultation form. Our international patient coordinators review your case within 24 hours.
2. Specialist Medical Review
A board-certified specialist in the relevant discipline reviews your diagnosis, imaging, and laboratory results to determine suitability for the program.
3. Personalized Treatment Plan
Based on the review, our medical team develops an individualized treatment protocol with detailed timelines, therapies, and estimated costs.
4. Travel & Accommodation Coordination
Our concierge team handles visa support letters, flight coordination, airport transfers, and accommodation in partner hotels near the health center.
5. On-Arrival Assessment & Treatment
Upon arrival, a final in-person assessment confirms the plan. Treatment begins under continuous multidisciplinary medical supervision.
Treatment Duration
Treatment duration varies by program and individual patient needs. Most international medical programs at La Pradera range from 2 to 6 weeks, allowing sufficient time for comprehensive assessment, therapeutic intervention, and recovery monitoring. Your personalized treatment plan will include a precise estimated timeline after the specialist medical review.
Patient Eligibility
- Adults (18+) with a confirmed medical diagnosis appropriate for the selected program
- Completed medical records including recent imaging and laboratory results
- Medical clearance for international travel
- No uncontrolled acute conditions that would prevent safe treatment
- Willingness to comply with the prescribed treatment protocol and follow-up schedule
- Valid passport and ability to obtain a Cuban medical visa (support letter provided)
Why Choose Cuba for Medical Treatment
Accredited by Cuba's Ministry of Public Health (MINSAP)
Decades of experience treating international patients from over 40 countries
Pioneering Cuban biotechnology: CIMAvax-EGF®, Heberprot-P®, NeuralCIM®
Transparent, all-inclusive pricing with no hidden fees
Frequently Asked Questions
How do I begin my medical treatment in Cuba?
Begin by submitting a consultation request through our online form. Our international patient coordinators will review your medical records and connect you with the appropriate specialist within 24 hours to develop a personalized treatment plan.
Do I need a visa to travel to Cuba for medical treatment?
Yes. International patients require a Cuban medical visa. La Pradera provides an official invitation letter once your treatment plan is confirmed, which you submit with your visa application at the Cuban consulate in your country.
Is the treatment at La Pradera covered by international health insurance?
Coverage depends on your insurance provider and policy. We recommend contacting your insurer before travel. La Pradera provides detailed medical reports and invoices that you can submit for reimbursement. Direct payment options are also available.
What language support is available for international patients?
Our international patient services team provides interpretation in English, Spanish, Arabic, French, Russian, Turkish, and other languages. Medical consultations are conducted with professional interpreters to ensure clear communication throughout your treatment.
Can a family member or companion accompany me during treatment?
Yes. We encourage patients to travel with a companion. Accommodation can be arranged for family members in nearby partner hotels, and our concierge team assists with their travel and stay arrangements.
Explore Other Programs
Riabilitazione Fisica
Riabilitazione fisica completa, intensa e personalizzata per bambini e adulti con condizioni neurolo
Learn moreQualità della Vita
Prevenzione delle malattie e diagnosi precoce tramite valutazioni sanitarie personalizzate. Promuovi
Learn moreMedicina Ayurvedica
La „Scienza della Vita“ — saggezza ancestrale con oltre 5.000 anni di applicazione. Terapie che ripr
Learn moreEmodialisi in Vacanza
Godetevi la vacanza a Cuba senza interrompere il trattamento di emodialisi. Un completo supporto med
Learn moreTipi di Cancro che Trattiamo
Informazioni dettagliate su condizioni specifiche trattate nel nostro programma.
Panoramica
Lung cancer is one of the most common and serious types of cancer worldwide. La Pradera offers treatment with CIMAvax-EGF®, the world's first therapeutic vaccine for non-small-cell lung cancer (NSCLC), developed by Cuba's Center of Molecular Immunology (CIM). Unlike preventive vaccines, CIMAvax-EGF® stimulates the patient's immune system to produce antibodies against epidermal growth factor (EGF), depriving cancer cells of the protein they need to multiply and grow.
Chi Può Beneficiarne
Adults diagnosed with stage IIIB or IV non-small-cell lung cancer (NSCLC) who have completed or are completing first-line oncology treatment (chemotherapy or radiotherapy). The vaccine is used as maintenance therapy to help control tumor growth and extend survival.
Procedura
After eligibility assessment, patients receive a series of intramuscular injections of CIMAvax-EGF® over a structured treatment protocol. The regimen begins with an induction phase of 5 doses in the first month, followed by monthly maintenance injections. Treatment is administered under continuous medical supervision with regular imaging and blood work to monitor response.
Vantaggi
- Stimulates the body's own immune system to target cancer cells
- Low toxicity profile compared to conventional chemotherapy
- Outpatient administration — no hospitalization required for each dose
- Improves quality of life during maintenance phase
- Developed by Cuba's Center of Molecular Immunology with over a decade of clinical use
Controindicazioni
Not suitable for patients with small-cell lung cancer (SCLC), pregnant or breastfeeding women, patients with active autoimmune diseases, or those with severe uncontrolled medical conditions. A full medical evaluation determines eligibility.
Risultati Attesi
Clinical studies indicate that CIMAvax-EGF® can slow disease progression and improve survival in eligible patients, particularly those with high EGF levels. Results vary by individual; the medical team provides a personalized prognosis after reviewing each case.
Innovazioni Mediche Cubane
Programmi Medici · La Pradera
CIMAvax-EGF®
Vaccino terapeutico per il cancro al polmone.
VAXIRA®
Vaccino terapeutico sviluppato da scienziati cubani e argentini.
HEBERSaVax®
Nuovo vaccino terapeutico sviluppato dal CIGB.
VIDATOX® 30CH
Medicinale omeopatico dal veleno dello scorpione blu.
Riferimenti Scientifici
- 1Rodríguez PC, et al. CIMAvax-EGF immunotherapy in advanced non-small cell lung cancer: Survival and immune response. Clinical Cancer Research.Fonte: Center of Molecular Immunology (CIM)Vedi riferimento
- 2Rodríguez PC, et al. CIMAvax-EGF: A novel therapeutic vaccine for non-small-cell lung cancer. Journal of Clinical Oncology.Fonte: Center of Molecular Immunology (CIM), Havana, CubaVedi riferimento
- 3Berlanga Acosta J, et al. Heberprot-P: Recombinant human epidermal growth factor for diabetic foot ulcers. International Wound Journal.Fonte: Center for Genetic Engineering and Biotechnology (CIGB), Havana, CubaVedi riferimento
- 4Cuban Ministry of Public Health (MINSAP). National Health Statistics Annual Report.Fonte: Ministry of Public Health of CubaVedi riferimento
Utilizziamo i cookie per migliorare la tua esperienza e analizzare il traffico. Continuando, accetti il nostro uso dei cookie. Informativa sulla Privacy